Elias Sayour, MD
Basic profileAssociate professor of neurosurgery and pediatrics at the University of Florida · University of Florida Health
Elias Sayour is Associate professor of neurosurgery and pediatrics at the University of Florida at University of Florida Health. OpenAlex indexes 243 publications with 3,851 citations (h-index 32); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Updated 25 Oct 2026
Elias Sayour, MD, is Associate professor of neurosurgery and pediatrics at the University of Florida. The public record shows 243 publications with 3,877 citations (h-index 32), centered on Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Glioma Diagnosis and Treatment. It also documents an investigator role on 6 registered clinical trials, 5 NIH-funded awards (2016–2026).
- Most recent indexed publication: 2026 · Nature cancer
- Top research focus: Immunotherapy and Immune Responses
- 6 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 48.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 32610-3003
Telephone
352-273-9000Registry record last updated 21 Nov 2013 · collected 28 Jul 2026.
Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Universal Immunization to Fortify Immunotherapy Efficacy and Response
Sponsor: University of Florida
- RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Sponsor: University of Florida
- Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Sponsor: Sabine Mueller, MD, PhD
NIH funding
Updated 25 Oct 2026
5 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
University of Florida
FY2026$1,245,669R01FD007268 - Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
University of Florida
FY2026$767,498R37CA251978
Congress activity
Updated 25 Oct 2026
23 congress contributions (2015–2026) across AACR, ADA, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract NG05: Mechanisms by which mRNA vaccines augment responses to immune checkpoint blockade
AACR Annual Meeting
AACR2026Co-author - Abstract 4164: Targeting glycogen metabolism as a potential therapy for Ewing sarcoma
AACR Annual Meeting
AACR2025Co-author - Abstract 5841: SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity.
Human vaccines & immunotherapeutics
Article2025 - Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors.
Journal for immunotherapy of cancer
Clinical Trial2025 - Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading.
Nature biomedical engineering
Article2025
Most-cited works
by citation count (OpenAlex)- 01CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumorsArticle388 citations2019
- 02Cancer mRNA vaccines: clinical advances and future opportunitiesReview237 citations2024
- 03
- 04CD70, a novel target of CAR T-cell therapy for gliomasArticle212 citations2017
- 05
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/elias-sayour-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
PhD
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurosurgery.ufl.edu ↗
Editorial & leadership roles
journal and society appointments- Assistant Dean for Research
UF College of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.drgator.ufl.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →innovate.research.ufl.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →solvingkidscancer.podbean.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jamie Conti, MD
University of Florida Health
Westley Reeves, MD
University of Florida Health
Borna Mehrad, MD
University of Florida Health
Joanne Lagmay, MD
University of Florida Health
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”